Prospectus
Filed with ASX · · 56 pages · English
Summary by 6ix AI
This filing is a prospectus from Lumos Diagnostics Holdings Ltd. detailing an offer of shares and options to raise funds. The prospectus outlines a share purchase plan and placement options for eligible shareholders, aiming to raise a specified amount before costs. It includes important information regarding eligibility, application procedures, and the speculative nature of the investment. The document emphasizes that it should be read in full before making any investment decisions.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/prospectus-134
Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20Read the transcript of Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings CallLumos Diagnostics Holdings Ltd. on 6ix
Story so far
Earlier from Lumos Diagnostics
- Lumos secures new contract manufacturing agreement
- Lumos receives largest FebriDx order to date
- Investor Presentation
- Lumos completes $20m placement and launches SPP
- US FDA Grants CLIA Waiver for FebriDx
Later from Lumos Diagnostics
- Response to ASX Aware Letter
- FebriDx Paediatric Study Enrolment Milestone Achieved
- FebriDx U.S. Rollout and Reimbursement Update
- FebriDx U.S. Rollout and Reimbursement Update - Amended
- FebriDx Commercial Traction Across Priority US Accounts
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics